MOTEGRITY Drug Patent Profile
✉ Email this page to a colleague
When do Motegrity patents expire, and what generic alternatives are available?
Motegrity is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in MOTEGRITY is prucalopride succinate. One supplier is listed for this compound. Additional details are available on the prucalopride succinate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MOTEGRITY?
- What are the global sales for MOTEGRITY?
- What is Average Wholesale Price for MOTEGRITY?
Summary for MOTEGRITY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 169 |
| Patent Applications: | 995 |
| Drug Prices: | Drug price information for MOTEGRITY |
| What excipients (inactive ingredients) are in MOTEGRITY? | MOTEGRITY excipients list |
| DailyMed Link: | MOTEGRITY at DailyMed |
Pharmacology for MOTEGRITY
| Drug Class | Serotonin-4 Receptor Agonist |
| Mechanism of Action | Serotonin 4 Receptor Agonists |
US Patents and Regulatory Information for MOTEGRITY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | MOTEGRITY | prucalopride succinate | TABLET;ORAL | 210166-001 | Dec 14, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Takeda Pharms Usa | MOTEGRITY | prucalopride succinate | TABLET;ORAL | 210166-002 | Dec 14, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
